Technically they're partly paid shares. Still have 2 years to run with then 10 cents owing to make a fully paid share.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025